| abstract |
The present invention provides fused heterocyclicnderivatives represented by the general formula:n nwherein R 1 represents H, halogen, OH, etc.; R 2 represents H,nhalogen or an alkyl group; R 3 and R 4 represent H, OH, halogen,netc.; Q represents alkylene, etc.; ring A represents aryl ornheteroaryl; and G representsn norn n or pharmaceutically acceptable salts thereof, or prodrugsnthereof, which exhibit an excellent inhibitory activity in humannSGLT and are useful as agents for the prevention or treatmentnof a disease associated with hyperglycemia such as diabetes,npostprandial hyperglycemia, impaired glucose tolerance,ndiabetic complications or obesity, pharmaceutical compositionsncomprising the same, and pharmaceutical uses thereof. |